Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.SenoRx, Inc. (SenoRx), a in vitro diagnostics company, announced its entry into the China market. SenoRx has begun marketing EnCor, its vacuum-assisted breast biopsy product, and its GelMark line of breast biopsy tissue markers through its distribution partner, Beijing Eastwide Medical Ltd.
Subscribe to our email newsletter
We are excited to enter the China market, which represents a continuation of our efforts to expand our international footprint in key markets where breast-care is increasingly becoming a national healthcare priority,” said Lloyd Malchow, SenoRx president and chief executive officer. “China remains one of the fastest growing economies in the world and has been devoting an increasing percentage of its gross domestic product (GDP) on improving healthcare for its people. Increasing awareness and detection of breast cancer in China has created a growing market for the latest minimally invasive vacuum-assisted breast biopsy technology.”
Malchow continued, “We further believe that the addition of John Buhler, Vice President of Global Sales and Business Development, who joined the SenoRx team in 2008 and brings many years of experience in establishing distribution and support within China coupled with BJEW, will strengthen our prospects in this key growth market.”